This device is designed to measure pressure and dimensions in the esophagus and pylorus in adults, helping to diagnose esophageal motility disorders.
The Endoflip™ system can be used during the first endoscopy, takes around five minutes to perform, and can be done under sedation.
Esophageal motility disorders are often difficult to diagnose, and Endoflip™ offers a convenient and well-tolerated method to assess these conditions.
The device uses a balloon catheter to measure the diameter at up to 16 points and displays real-time balloon pressure, which can aid in making a more accurate diagnosis and treatment plan right from the first endoscopy. This helps avoid unnecessary distress for patients.
The Endoflip™ 300 system is a valuable tool for physicians in diagnosing esophageal motility disorders earlier, allowing for better planning and more effective treatment. The technology is expected to improve patient outcomes by reducing misdiagnosis and the time spent waiting for proper treatment.
The Endoflip™ system’s ability to guide diagnosis early on is particularly valuable in reducing unnecessary tests, which not only cause patient distress but also incur significant healthcare costs.
By helping to avoid these unnecessary tests and improving diagnosis accuracy, Endoflip™ can ultimately save costs and enhance patient quality of life.
Key benefits of the Endoflip™ system include Comfortable procedure, performed under sedation, Quick, taking about 5 minutes to complete, Can be performed during the initial endoscopy, Real-time topography displayed on a screen, with established diagnostic ranges, Physicians trained in the system may make a diagnosis during the procedure.
By providing a faster and more precise diagnosis, Endoflip™ offers a significant advancement in the management of esophageal motility disorders.
Source: https://news.medtronic.com/Medtronic-receives-CE-Mark-for-its-next-generation-Endoflip-TM-300-system
